Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]Martinostat in Breast Cancer
NCT03721211Phase 1Withdrawn
- Start
- Feb 2020
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 11C-Martinostat in breast cancer. Primary endpoint: PET-MRI Visualization and Quantification of Breast Tumor Uptake of [11C]Martinostat at 2 years. Planned start Feb 2020; status: withdrawn.
02
Drugs
11C-Martinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03721211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721211.